{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:49:12Z","timestamp":1791902952817,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1007\/s11882-002-0068-0","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T21:53:40Z","timestamp":1180821220000},"page":"361-367","source":"Crossref","is-referenced-by-count":12,"title":["X-linked lymphoproliferative disease: Genetic lesions and clinical consequences"],"prefix":"10.1007","volume":"2","author":[{"given":"Andrew J.","family":"MacGinnitie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raif","family":"Geha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"68_CR1","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0140-6736(75)92004-8","volume":"1","author":"DT Purtilo","year":"1975","unstructured":"Purtilo DT, Cassel CK, Yang JP, Harper R: X-linked recessive progressive combined variable immunodeficiency (Duncan\u2019s disease). Lancet 1975, 1:935\u2013940.","journal-title":"Lancet"},{"key":"68_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","volume":"38","author":"TA Seemayer","year":"1995","unstructured":"Seemayer TA, Gross TG, Egeler RM, et al.: X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995, 38:471\u2013478.","journal-title":"Pediatr Res"},{"key":"68_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0022-3476(80)80735-9","volume":"96","author":"JK Hamilton","year":"1980","unstructured":"Hamilton JK, Paquin LA, Sullivan JL, et al.: X-linked lymphoproliferative syndrome registry report. J Pediatr 1980, 96:669\u2013673.","journal-title":"J Pediatr"},{"key":"68_CR4","first-page":"1242","volume":"147","author":"TA Seemayer","year":"1993","unstructured":"Seemayer TA, Grierson H, Pirruccello SJ, et al.: X-linked lymphoproliferative disease. Am J Dis Child 1993, 147:1242\u20131245.","journal-title":"Am J Dis Child"},{"key":"68_CR5","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1182\/blood.V98.5.1321","volume":"98","author":"M Morra","year":"2001","unstructured":"Morra M, Silander O, Calpe S, et al.: Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood 2001, 98:1321\u20131325. Reports on six patients diagnosed with common variable immunodeficiency subsequently found to have mutations in the SAP gene. Four of six died of infection or complications of infections.","journal-title":"Blood"},{"key":"68_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1046\/j.1365-2249.2001.01599.x","volume":"126","author":"K Nistala","year":"2001","unstructured":"Nistala K, Gilmour KC, Cranston T, et al.: X-linked lymphoproliferative disease: three atypical cases. Clin Exp Immunol 2001, 126:126\u2013130. Describes three patients diagnosed with common variable immunodeficiency with no SAP expression. The index patient went on to develop fatal fulminant infectious mononucleosis.","journal-title":"Clin Exp Immunol"},{"key":"68_CR7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1182\/blood.V98.4.1268","volume":"98","author":"R Sumazaki","year":"2001","unstructured":"Sumazaki R, Kanegane H, Osaki M, et al.: SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses. Blood 2001, 98:1268\u20131270. The authors studied 40 males with severe EBV-associated disease, and identified 10 who had SAP mutations. Nine had fulminant infectious mononucleosis and one an EBV-positive lymphoma.","journal-title":"Blood"},{"key":"68_CR8","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/blood.V97.4.1131","volume":"97","author":"M Arico","year":"2001","unstructured":"Arico M, Imashuku S, Clementi R, et al.: Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood 2001, 97:1131\u20131133. A study reporting that four of 25 patients with apparently sporadic hemophagocytic lymphohistiocytosis secondary to EBV had muations in SAP.","journal-title":"Blood"},{"key":"68_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJM199501053320112","volume":"332","author":"D Liebowitz","year":"1995","unstructured":"Liebowitz D: Epstein-Barr virus--an old dog with new tricks. N Engl J Med 1995, 332:55\u201357.","journal-title":"N Engl J Med"},{"key":"68_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/jama.278.6.510","volume":"278","author":"JI Cohen","year":"1997","unstructured":"Cohen JI: Epstein-Barr virus and the immune system. Hide and seek. JAMA 1997, 278:510\u2013513.","journal-title":"JAMA"},{"key":"68_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/aje\/154.2.161","volume":"154","author":"M Wrensch","year":"2001","unstructured":"Wrensch M, Weinberg A, Wiencke J, et al.: Prevalence of antibodies to four herpesviruses among adults with glioma and controls. Am J Epidemiol 2001, 154:161\u2013165.","journal-title":"Am J Epidemiol"},{"key":"68_CR12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/15513819109065466","volume":"11","author":"DT Purtilo","year":"1991","unstructured":"Purtilo DT, Grierson HL, Davis JR, Okano M: The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975\u20131990. Pediatr Pathol 1991, 11:685\u2013710.","journal-title":"Pediatr Pathol"},{"key":"68_CR13","first-page":"1","volume":"72","author":"S Imashuku","year":"2000","unstructured":"Imashuku S: Advances in the management of hemophagocytic lymphohistiocytosis. Int J Hematol 2000, 72:1\u201311.","journal-title":"Int J Hematol"},{"key":"68_CR14","first-page":"3118","volume":"96","author":"J Sumegi","year":"2000","unstructured":"Sumegi J, Huang D, Lanyi A, et al.: Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood 2000, 96:3118\u20133125.","journal-title":"Blood"},{"key":"68_CR15","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4049\/jimmunol.129.6.2532","volume":"129","author":"S Harada","year":"1982","unstructured":"Harada S, Sakamoto K, Seeley JK, et al.: Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects. J Immunol 1982, 129:2532\u20132535.","journal-title":"J Immunol"},{"key":"68_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ajmg.1320400309","volume":"40","author":"HL Grierson","year":"1991","unstructured":"Grierson HL, Skare J, Hawk J, et al.: Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Am J Med Genet 1991, 40:294\u2013297.","journal-title":"Am J Med Genet"},{"key":"68_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 92:34\u201348.","journal-title":"Clin Immunol"},{"key":"68_CR18","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/1097-0142(19870415)59:8<1419::AID-CNCR2820590807>3.0.CO;2-P","volume":"59","author":"DS Harrington","year":"1987","unstructured":"Harrington DS, Weisenburger DD, Purtilo DT: Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer 1987, 59:1419\u20131429.","journal-title":"Cancer"},{"key":"68_CR19","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1093\/hmg\/8.13.2407","volume":"8","author":"O Brandau","year":"1999","unstructured":"Brandau O, Schuster V, Weiss M, et al.: Epstein-Barr virusnegative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). Hum Mol Genet 1999, 8:2407\u20132413.","journal-title":"Hum Mol Genet"},{"key":"68_CR20","first-page":"A331","volume":"65","author":"L Yin","year":"1999","unstructured":"Yin L, Toccco T, Pauly S, et al.: Absence of SH2D1A point mutations in 62 Burkitts lymphoma cell lines. Am J Hum Genet 1999, 65(Suppl):A331.","journal-title":"Am J Hum Genet"},{"key":"68_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0003-4975(99)00603-7","volume":"68","author":"VK Mehta","year":"1999","unstructured":"Mehta VK, Massad MG, Tripathi SP, et al.: Immune-deficient bronchiectasis associated with X-linked lymphoproliferative disease. Ann Thorac Surg 1999, 68:578\u2013580.","journal-title":"Ann Thorac Surg"},{"key":"68_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1182\/blood.V97.1.95","volume":"97","author":"JP Dutz","year":"2001","unstructured":"Dutz JP, Benoit L, Wang X, et al.: Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood 2001, 97:95\u2013100.","journal-title":"Blood"},{"key":"68_CR23","first-page":"546","volume":"109","author":"S Loeffel","year":"1985","unstructured":"Loeffel S, Chang CH, Heyn R, et al.: Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome. Arch Pathol Lab Med 1985, 109:546\u2013550.","journal-title":"Arch Pathol Lab Med"},{"key":"68_CR24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0161-6420(94)31275-9","volume":"101","author":"HE Grossniklaus","year":"1994","unstructured":"Grossniklaus HE, Aaberg TM, Purnell EW, et al.: Retinal necrosis in X-linked lymphoproliferative disease. Ophthalmology 1994, 101:705\u2013709.","journal-title":"Ophthalmology"},{"key":"68_CR25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.4049\/jimmunol.128.2.904","volume":"128","author":"K Sakamoto","year":"1982","unstructured":"Sakamoto K, Seeley JK, Lindsten T, et al.: Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk. J Immunol 1982, 128:904\u2013907.","journal-title":"J Immunol"},{"key":"68_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","volume":"28","author":"JI Henter","year":"1997","unstructured":"Henter JI, Arico M, Egeler RM, et al.: HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study group of the Histiocyte Society. Med Pediatr Oncol 1997, 28:342\u2013347.","journal-title":"Med Pediatr Oncol"},{"key":"68_CR27","first-page":"222","volume":"42","author":"AH Filipovich","year":"1986","unstructured":"Filipovich AH, Blazar BR, Ramsay NK, et al.: Allogeneic bone marrow transplantation for X-linked lymphoproliferative syndrome. Transplantation 1986, 42:222\u2013224.","journal-title":"Transplantation"},{"key":"68_CR28","first-page":"655","volume":"13","author":"E Pracher","year":"1994","unstructured":"Pracher E, Panzer-Grumayer ER, et al.: Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis. Bone Marrow Transplant 1994, 13:655\u2013658.","journal-title":"Bone Marrow Transplant"},{"key":"68_CR29","first-page":"741","volume":"17","author":"TG Gross","year":"1996","unstructured":"Gross TG, Filipovich AH, Conley ME, et al.: Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 1996, 17:741\u2013744.","journal-title":"Bone Marrow Transplant"},{"key":"68_CR30","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood.V99.3.872","volume":"99","author":"LA Myers","year":"2002","unstructured":"Myers LA, Patel DD, Puck JM, Buckley RH: Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002, 99:872\u2013878.","journal-title":"Blood"},{"key":"68_CR31","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1056\/NEJM199311253292205","volume":"329","author":"MR Vowels","year":"1993","unstructured":"Vowels MR, Tang RL, Berdoukas V, et al.: Brief report: correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells. N Engl J Med 1993, 329:1623\u20131625.","journal-title":"N Engl J Med"},{"key":"68_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1126\/science.288.5466.669","volume":"288","author":"M Cavazzana-Calvo","year":"2000","unstructured":"Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al.: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000, 288:669\u2013672.","journal-title":"Science"},{"key":"68_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.192.3.337","volume":"192","author":"S Parolini","year":"2000","unstructured":"Parolini S, Bottino C, Falco M, et al.: X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J Exp Med 2000, 192:337\u2013346.","journal-title":"J Exp Med"},{"key":"68_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1084\/jem.194.3.235","volume":"194","author":"C Bottino","year":"2001","unstructured":"Bottino C, Falco M, Parolini S, et al.: NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J Exp Med 2001, 194:235\u2013246.","journal-title":"J Exp Med"},{"key":"68_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1126\/science.6158759","volume":"210","author":"JL Sullivan","year":"1980","unstructured":"Sullivan JL, Byron KS, Brewster FE, Purtilo DT: Deficient natural killer cell activity in x-linked lymphoproliferative syndrome. Science 1980, 210:543\u2013545.","journal-title":"Science"},{"key":"68_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0008-8749(86)90001-8","volume":"100","author":"S Argov","year":"1986","unstructured":"Argov S, Johnson DR, Collins M, et al.: Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome. Cell Immunol 1986, 100:1\u20139.","journal-title":"Cell Immunol"},{"key":"68_CR37","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/26683","volume":"395","author":"J Sayos","year":"1998","unstructured":"Sayos J, Wu C, Morra M, et al.: The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998, 395:462\u2013469.","journal-title":"Nature"},{"key":"68_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/2424","volume":"20","author":"AJ Coffey","year":"1998","unstructured":"Coffey AJ, Brooksbank RA, Brandau O, et al.: Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998, 20:129\u2013135.","journal-title":"Nat Genet"},{"key":"68_CR39","doi-asserted-by":"publisher","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","volume":"95","author":"KE Nichols","year":"1998","unstructured":"Nichols KE, Harkin DP, Levitz S, et al.: Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A 1998, 95:13765\u201313770.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"68_CR40","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1093\/intimm\/12.12.1749","volume":"12","author":"J Sayos","year":"2000","unstructured":"Sayos J, Nguyen KB, Wu C, et al.: Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. Int Immunol 2000, 12:1749\u20131757.","journal-title":"Int Immunol"},{"key":"68_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1097-2765(00)80206-3","volume":"4","author":"F Poy","year":"1999","unstructured":"Poy F, Yaffe MB, Sayos J, et al.: Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol Cell 1999, 4:555\u2013561.","journal-title":"Mol Cell"},{"key":"68_CR42","doi-asserted-by":"publisher","first-page":"36809","DOI":"10.1074\/jbc.M101305200","volume":"276","author":"M Morra","year":"2001","unstructured":"Morra M, Simarro-Grande M, Martin M, et al.: Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients. J Biol Chem 2001, 276:36809\u201336816.","journal-title":"J Biol Chem"},{"key":"68_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/ni0901-823","volume":"2","author":"C Wu","year":"2001","unstructured":"Wu C, Nguyen KB, Pien GC, et al.: SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol 2001, 2:410\u2013414.","journal-title":"Nat Immunol"},{"key":"68_CR44","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1073\/pnas.131193098","volume":"98","author":"MJ Czar","year":"2001","unstructured":"Czar MJ, Kersh EN, Mijares LA, et al.: Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A\/DSHP\/ SAP. Proc Natl Acad Sci U S A 2001, 98:7449\u20137454.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"68_CR45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.immunol.19.1.657","volume":"19","author":"M Morra","year":"2001","unstructured":"Morra M, Howie D, Grande MS, et al.: X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu Rev Immunol 2001, 19:657\u2013682.","journal-title":"Annu Rev Immunol"},{"key":"68_CR46","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.4049\/jimmunol.162.12.6981","volume":"162","author":"SG Tangye","year":"1999","unstructured":"Tangye SG, Lazetic S, Woollatt E, et al.: Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 1999, 162:6981\u20136985.","journal-title":"J Immunol"},{"key":"68_CR47","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.165.7.3549","volume":"165","author":"L Benoit","year":"2000","unstructured":"Benoit L, Wang X, Pabst HF, et al.: Defective NK cell activation in X-linked lymphoproliferative disease. J Immunol 2000, 165:3549\u20133553.","journal-title":"J Immunol"},{"key":"68_CR48","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/90615","volume":"2","author":"S Latour","year":"2001","unstructured":"Latour S, Gish G, Helgason CD, et al.: Regulation of SLAMmediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat Immunol 2001, 2:681\u2013690. This study Identified a potentially new role for SAP in intracellular signaling. SAP can change the conformation of the intracellular portion of SLAM, allowing recruitment of the Fyn tyrosine kinase.","journal-title":"Nat Immunol"},{"key":"68_CR49","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.1073\/pnas.130193097","volume":"97","author":"BS Sylla","year":"2000","unstructured":"Sylla BS, Murphy K, Cahir-McFarland E, et al.: The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B. Proc Natl Acad Sci U S A 2000, 97:7470\u20137475. This report demonstrated an association of SAP with p62dok, and showed that SAP can activate NK-_B. This further expands the number of pathways in which SAP is apparently involved.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-002-0068-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-002-0068-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-002-0068-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-002-0068-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T19:02:00Z","timestamp":1707937320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-002-0068-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1007\/s11882-002-0068-0","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}